Authors




Morgan L. Bixby, BS

Latest:

What’s New in 2023 From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

This year's Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing provided updated breakpoints on therapies.


Luke Buxton, DO

Latest:

Nonventilator Hospital-Acquired Pneumonia: Epidemiology, Prevention, and Where It Is Now

The management of hospital-acquired pneumonia requires use of preventive bundles, mitigative of risk factors, and prompt diagnosis with initiation of treatment when highly suspected.


Jon Matthew Farber, MD

Latest:

Fluoroquinolone Safe for Treating Severe Refractory M Pneumoniae Pneumonia

Investigators asked the children’s parents about the history of musculoskeletal-related disease, observed the children’s gait, and performed physical examinations.


Steve Mok, PharmD, MBA, BCPS, BCIDP

Latest:

Preparing for AUR Reporting Mandates to Capitalize on Quality Reimbursement

The mandatory reporting of Antimicrobial Use and Resistance (AUR) by hospitals participating in the CMS Medicare Promoting Interoperability Program beginning next year is a important strategy in curbing the overuse of antibiotics.


Ian Cook, PharmD

Latest:

Examining the HIV Treatment Pipeline

A review of selected investigational long-active treatment options for HIV.




Madeline King-Patel, PharmD, BCIDP

Latest:

Should Linezolid Replace Clindamycin for Necrotizing Soft Tissue Infections?

A comparative study found that using linezolid in place of clindamycin in combination with vancomycin for the treatment of necrotizing soft tissue infections resulted in similar 30-day mortality rates but lower rates of acute kidney injury and composite adverse outcomes, suggesting the effectiveness and safety of linezolid as an alternative therapy.



Mackenzie Keintz, MD

Latest:

Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant Foe

Salmonella becomes more dangerous as antimicrobial resistance grows. Read about its most common manifestations.


David Pitrak, MD

Latest:

Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.


Hugh Davis, MD

Latest:

Final Diagnosis: Donor-Derived Staphylococcus Iugdunensis Endocarditis of Transplanted Heart

"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "


Caleb C. McLeod, PharmD

Latest:

Cefiderocol’s Role in Managing Carbapenem-Resistant Acinetobacter baumannii Infections

This agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.


Meagan Mayo, DO

Latest:

Pulmonary Coinfection With C neoformans and C immitis: A Novel Fungal Cohabitation

A patient presented with a history of uncontrolled HIV and a history of polysubstance use.


Jessica Irish, PharmD Candidate

Latest:

Need for Speed: Rapid Antiretroviral Initiation in the Emergency Department

Emergency departments (EDs) are an important entry point into the health care system and have been identified as a location with opportunity for increased HIV diagnosis and management.


Bennett Waxse, MD, PhD

Latest:

Improving Screening, Management of Hepatitis C in Infants and Children

Despite hepatitis C (HCV) incidence rates increasing, adequate screening for the virus continues to be a pressing challenge for public health officials.



Scott Curry, MD

Latest:

Exploring the Recently Approved and Upcoming Clostridioides difficile Therapeutics

This market has seen a flurry of activity, as shown by a review of the latest agents.


Myriam Shaw Ojeda, PharmD

Latest:

Assisting With International Health Care Needs

Although the pandemic halted many medical mission assignments, these opportunities and others are becoming available to help those geographic areas with acute needs.


Gerard Jacinto, PharmD

Latest:

Should Cefazolin be Prescribed in Patients With B-lactam Allergies?

For patients undergoing surgery, looking at the potential benefits of this antimicrobial for prophylaxis.


Meghan Lyman, MD

Latest:

Candida auris: Coming Soon to a Facility Near You?

Epidemiologic and clinical lessons for the uninitiated.


Amy L. Carr, PharmD, BCIDP

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Kyle H. Lee

Latest:

That’s Not Appropriate: A Look at Antibiotic Prescribing Post Discharge

Extending antimicrobial stewardship programs to transition of care and discharge may prove beneficial to reduce unnecessary antibiotic use.


Jacinda C. Abdul-Mutakabbir, PharmD, MPH, AAHIVP

Latest:

Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.


Sophia Abene

Latest:

The Norovirus Surge Across the United States

Norovirus cases rise in the northeast and are spreading across the nation.


Marissa Cavaretta, PharmD, BCPS, BCACP

Latest:

Sticking It to COVID-19: The Expansion of the Pfizer-BioNTech Vaccine EUA

A review of the data and circumstances that led to authorization in children ages 5 to 11 years.


Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM

Latest:

Opposing Forces During COVID-19: Perspective From the ICU

Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.


Maureen McElligott, MD

Latest:

Opposing Forces During COVID-19: Perspective From the ICU

Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.

© 2024 MJH Life Sciences

All rights reserved.